- Home
- VMEO vs BGM Comparison
VMEO vs BGM Comparison
Compare VMEO & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMEO
- BGM
- Stock Information
- Founded
- VMEO 2004
- BGM 2019
- Country
- VMEO United States
- BGM China
- Employees
- VMEO N/A
- BGM N/A
- Industry
- VMEO Computer Software: Prepackaged Software
- BGM
- Sector
- VMEO Technology
- BGM
- Exchange
- VMEO Nasdaq
- BGM NYSE
- Market Cap
- VMEO 832.5M
- BGM 962.5M
- IPO Year
- VMEO N/A
- BGM 2021
- Fundamental
- Price
- VMEO $4.89
- BGM $10.87
- Analyst Decision
- VMEO Buy
- BGM
- Analyst Count
- VMEO 3
- BGM 0
- Target Price
- VMEO $8.67
- BGM N/A
- AVG Volume (30 Days)
- VMEO 1.2M
- BGM 25.7K
- Earning Date
- VMEO 05-05-2025
- BGM 04-15-2025
- Dividend Yield
- VMEO N/A
- BGM N/A
- EPS Growth
- VMEO 19.88
- BGM N/A
- EPS
- VMEO 0.16
- BGM N/A
- Revenue
- VMEO $417,006,000.00
- BGM $25,097,951.00
- Revenue This Year
- VMEO $4.16
- BGM N/A
- Revenue Next Year
- VMEO $6.76
- BGM N/A
- P/E Ratio
- VMEO $33.69
- BGM N/A
- Revenue Growth
- VMEO N/A
- BGM N/A
- 52 Week Low
- VMEO $3.43
- BGM $2.70
- 52 Week High
- VMEO $7.90
- BGM $14.78
- Technical
- Relative Strength Index (RSI)
- VMEO 29.44
- BGM 53.14
- Support Level
- VMEO $5.31
- BGM $10.71
- Resistance Level
- VMEO $5.34
- BGM $11.50
- Average True Range (ATR)
- VMEO 0.16
- BGM 1.00
- MACD
- VMEO -0.02
- BGM 0.03
- Stochastic Oscillator
- VMEO 7.65
- BGM 55.06
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. The comprehensive and cloud-based tools of the company empower its users to create, share, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.